{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:18:57Z","timestamp":1792185537724,"version":"4.4.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/fjc.0b013e31823f888f","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T10:07:53Z","timestamp":1320919673000},"page":"268-280","source":"Crossref","is-referenced-by-count":49,"title":["Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice"],"prefix":"10.1097","volume":"59","author":[{"given":"Yunzeng","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210227","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"R2-9-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","article-title":"Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.","volume":"114","author":"Koren","year":"1991","journal-title":"Ann Intern Med"},{"key":"R3-9-20210227","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0735-1097(01)01663-1","article-title":"Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study.","volume":"38","author":"Verdecchia","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R4-9-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly.","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"R5-9-20210227","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jama.288.12.1491","article-title":"Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophya Losartan Intervention For Endpoint Reduction (LIFE) substudy.","volume":"288","author":"Kjeldsen","year":"2002","journal-title":"JAMA"},{"key":"R6-9-20210227","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0008-6363(98)00305-8","article-title":"Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors.","volume":"41","author":"Nicoletti","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R7-9-20210227","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1253\/circj.CJ-09-0741","article-title":"Large blood pressure variability and hypertensive cardiac remodelingrole of cardiac inflammation.","volume":"73","author":"Kai","year":"2009","journal-title":"Circ J"},{"key":"R8-9-20210227","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1161\/01.CIR.0000147233.10318.23","article-title":"Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.","volume":"110","author":"Sun","year":"2004","journal-title":"Circulation"},{"key":"R9-9-20210227","doi-asserted-by":"crossref","first-page":"H106","DOI":"10.1152\/ajpheart.01327.2005","article-title":"Significance of changes in TNF- and IL-10 levels in the progression of heart failure subsequent to myocardial infarction.","volume":"291","author":"Kaur","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R10-9-20210227","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"key":"R12-9-20210227","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease.","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Invest"},{"key":"R13-9-20210227","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinasestissue inhibitors of metalloproteinasesrelationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"R14-9-20210227","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways.","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ Res"},{"key":"R15-9-20210227","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/14779072.6.8.1135","article-title":"Role of IGF-1 in glucose regulation and cardiovascular disease.","volume":"6","author":"Abbas","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R16-9-20210227","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1440-1681.2007.04873.x","article-title":"Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease.","volume":"35","author":"McMullen","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R17-9-20210227","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1172\/JCI118747","article-title":"Apoptosis in pressure overload-induced heart hypertrophy in the rat.","volume":"97","author":"Teiger","year":"1996","journal-title":"J Clin Invest"},{"key":"R18-9-20210227","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jtcvs.2008.12.020","article-title":"Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium.","volume":"137","author":"Choi","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-9-20210227","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.108.186551","article-title":"Autophagy in load-induced heart disease.","volume":"103","author":"Rothermel","year":"2008","journal-title":"Circ Res"},{"key":"R21-9-20210227","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm1574","article-title":"The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.","volume":"13","author":"Nakai","year":"2007","journal-title":"Nat Med"},{"key":"R22-9-20210227","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1172\/JCI27523","article-title":"Cardiac autophagy is a maladaptive response to hemodynamic stress.","volume":"117","author":"Zhu","year":"2007","journal-title":"J Clin Invest"},{"key":"R23-9-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-physiol-021909-135757","article-title":"Autophagy during cardiac stress: joys and frustrations of autophagy.","volume":"72","author":"Gottlieb","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"R24-9-20210227","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.yjmcc.2008.02.278","article-title":"ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.","volume":"44","author":"Fuller","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"R25-9-20210227","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","article-title":"Neuregulin1ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.","volume":"138","author":"Bersell","year":"2009","journal-title":"Cell"},{"key":"R26-9-20210227","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2010.11.036","article-title":"CEBP controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.","volume":"143","author":"Bostrom","year":"2010","journal-title":"Cell"},{"key":"R27-9-20210227","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.CIR.64.5.958","article-title":"Noninvasive evaluation of exercise training in college-age men.","volume":"64","author":"Adams","year":"1981","journal-title":"Circulation"},{"key":"R28-9-20210227","first-page":"55","article-title":"Clinical observation of randomized double-blind and multicenter trial on Qiliqiangxin capsule in the treatment of chronic heart failure.","volume":"6","author":"Wu","year":"2007","journal-title":"Chin J Difficult Complicated Cases"},{"key":"R29-9-20210227","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-2005-873126","article-title":"Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro.","volume":"72","author":"Zhang","year":"2006","journal-title":"Planta Med"},{"key":"R30-9-20210227","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ptr.1778","article-title":"Panax ginseng reduces adriamycin-induced heart failure in rats.","volume":"19","author":"You","year":"2005","journal-title":"Phytother Res"},{"key":"R31-9-20210227","first-page":"49","article-title":"Therapeutic effect of Qiliqiangxin capsule on the patients with chronic congestive heart failure.","volume":"5","author":"Ling","year":"2008","journal-title":"Chin J Difficult Complicated Cases"},{"key":"R32-9-20210227","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cellimm.2009.09.001","article-title":"Qiliqiangxin regulates the balance between tumor necrosis factor- and interleukin-10 and improves cardiac function in rats with myocardial infarction.","volume":"260","author":"Xiao","year":"2009","journal-title":"Cell Immunol"},{"key":"R33-9-20210227","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1440-1681.2003.03917.x","article-title":"Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats.","volume":"30","author":"Li","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R34-9-20210227","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.","volume":"6","author":"Zou","year":"2004","journal-title":"Nat Cell Biol"},{"key":"R35-9-20210227","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/hr.2010.182","article-title":"Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice.","volume":"33","author":"Li","year":"2010","journal-title":"Hypertens Res"},{"key":"R36-9-20210227","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4161\/cc.5.9.2733","article-title":"Stop and go: anti-proliferative and mitogenic functions of the transcription factor CEBP.","volume":"5","author":"Sebastian","year":"2006","journal-title":"Cell Cycle"},{"key":"R37-9-20210227","first-page":"170","article-title":"Inhibition of periostin by Qiliqiangxin to improve ventricular remodeling in heart failure rats.","volume":"13","author":"Li","year":"2009","journal-title":"Chin J Lab Diagnos"},{"key":"R38-9-20210227","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jep.2007.09.027","article-title":"Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk.","volume":"115","author":"Ryu","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"R39-9-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8546-4-6","article-title":"Effects of astragaloside IV on heart failure in rats.","volume":"4","author":"Zhao","year":"2009","journal-title":"Chin Med"},{"key":"R40-9-20210227","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxlet.2008.08.002","article-title":"Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis.","volume":"182","author":"Zhao","year":"2008","journal-title":"Toxicol Lett"},{"key":"R41-9-20210227","first-page":"205","article-title":"Effect of Shenfu injection on ischemia-reperfusion injury of rat liver graft.","volume":"5","author":"Zhu","year":"2006","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R43-9-20210227","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy.","volume":"6","author":"Levine","year":"2004","journal-title":"Dev Cell"},{"key":"R44-9-20210227","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0167-5273(08)70231-6","article-title":"The effects of traditional drug Qiliqiangxin on inflammatory cytokines expression in rats with acute myocardial infarction.","volume":"125","author":"Cheng","year":"2008","journal-title":"Int J Cardiol"},{"key":"R45-9-20210227","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0022-2828(03)00210-4","article-title":"Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors.","volume":"35","author":"Sato","year":"2003","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0b013e31823f888f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:19:53Z","timestamp":1620951593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-201203000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e31823f888f","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}